Corren J - Search Results

1

Lebrikizumab treatment in adults with asthma.

Corren J, Lemanske RF, Hanania NA, Korenblat PE, Parsey MV, Arron JR, Harris JM, Scheerens H, Wu LC, Su Z, Mosesova S, Eisner MD, Bohen SP, Matthews JG. Corren J, et al. N Engl J Med. 2011 Sep 22;365(12):1088-98. doi: 10.1056/NEJMoa1106469. Epub 2011 Aug 3. N Engl J Med. 2011. PMID: 21812663 Free article. Clinical Trial.

2

Comparison of the bronchodilatory effects of cetirizine, albuterol, and both together versus placebo in patients with mild-to-moderate asthma.

Spector SL, Nicodemus CF, Corren J, Schanker HM, Rachelefsky GS, Katz RM, Siegel SC. Spector SL, et al. Among authors: corren j. J Allergy Clin Immunol. 1995 Aug;96(2):174-81. doi: 10.1016/s0091-6749(95)70005-6. J Allergy Clin Immunol. 1995. PMID: 7636054 Clinical Trial.

3

Efficacy and safety of loratadine plus pseudoephedrine in patients with seasonal allergic rhinitis and mild asthma.

Corren J, Harris AG, Aaronson D, Beaucher W, Berkowitz R, Bronsky E, Chen R, Chervinsky P, Cohen R, Fourre J, Grossman J, Meltzer E, Pedinoff A, Stricker W, Wanderer A. Corren J, et al. J Allergy Clin Immunol. 1997 Dec;100(6 Pt 1):781-8. doi: 10.1016/s0091-6749(97)70274-4. J Allergy Clin Immunol. 1997. PMID: 9438487 Clinical Trial.

4

Effective control of asthma with hydrofluoroalkane flunisolide delivered as an extrafine aerosol in asthma patients.

Corren J, Nelson H, Greos LS, Bensch G, Goldstein M, Wu J, Wang S, Newman K. Corren J, et al. Ann Allergy Asthma Immunol. 2001 Nov;87(5):405-11. doi: 10.1016/S1081-1206(10)62922-5. Ann Allergy Asthma Immunol. 2001. PMID: 11730183 Clinical Trial.

5

Omalizumab, a recombinant humanized anti-IgE antibody, reduces asthma-related emergency room visits and hospitalizations in patients with allergic asthma.

Corren J, Casale T, Deniz Y, Ashby M. Corren J, et al. J Allergy Clin Immunol. 2003 Jan;111(1):87-90. doi: 10.1067/mai.2003.49. J Allergy Clin Immunol. 2003. PMID: 12532101 Clinical Trial.

6

Evaluation of efficacy and safety of flunisolide hydrofluoroalkane for the treatment of asthma.

Corren J, Tashkin DP. Corren J, et al. Clin Ther. 2003 Mar;25(3):776-98. doi: 10.1016/s0149-2918(03)80108-x. Clin Ther. 2003. PMID: 12852702 Review.

7

Comparison of once-daily mometasone furoate versus once-daily budesonide in patients with moderate persistent asthma.

Corren J, Berkowitz R, Murray JJ, Prenner B. Corren J, et al. Int J Clin Pract. 2003 Sep;57(7):567-72. Int J Clin Pract. 2003. PMID: 14529054 Clinical Trial.

8

Twelve-week, randomized, placebo-controlled, multicenter study of the efficacy and tolerability of budesonide and formoterol in one metered-dose inhaler compared with budesonide alone and formoterol alone in adolescents and adults with asthma.

Corren J, Korenblat PE, Miller CJ, O'Brien CD, Mezzanotte WS. Corren J, et al. Clin Ther. 2007 May;29(5):823-843. doi: 10.1016/j.clinthera.2007.05.011. Clin Ther. 2007. PMID: 17697902 Clinical Trial.

9

Daclizumab improves asthma control in patients with moderate to severe persistent asthma: a randomized, controlled trial.

Busse WW, Israel E, Nelson HS, Baker JW, Charous BL, Young DY, Vexler V, Shames RS; Daclizumab Asthma Study Group. Busse WW, et al. Am J Respir Crit Care Med. 2008 Nov 15;178(10):1002-8. doi: 10.1164/rccm.200708-1200OC. Epub 2008 Sep 11. Am J Respir Crit Care Med. 2008. PMID: 18787222 Clinical Trial.

10

Treating asthma in the new millennium.

Corren J. Corren J. Postgrad Med. 2000 Sep 15;108(4 Suppl):45-53. doi: 10.3810/pgm.09.15.2000.suppl7.43. Postgrad Med. 2000. PMID: 19667533

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

174 results

Search Page